Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr Fauci said during a couple of the CC that they would fund manufacturing to avoid any delay with vaccine or treatment. I'm hoping that's in play with lero if so the 100 million shares may not be necessary. IBIO has a fast pharming system developed in part by the government (darpa) to be used in this exact situation. To mass produce very fast during a pandemic. I don't know if that system would work with lero but if so I would think the gov will pull out all stops to move this forward.
Right now today billions of dollars from Leronlimab
I have to disagree with the risk as being high. If Leronlimab only had lab data then I would consider the risk high but with many different actual patients from different indications having such an incredible response puts the risk at very low.
The run up hasn't even started yet, if you want shares below $6 you better buy now.
But..but..but.. I don't understand what's going on? The bollinger bands? The market responding? The dead cat bounced and everything. I just don't understand how CYDY price could be going up like this.
There's one major thing missing with ever news story about a potential treatment and that's the words FDA APPROVED TREATMENT. So far Cytodyn is leading the pack. The party hasn't even started yet.
Nope wrong on this one HIV is complete, meeting all end points. Revenue within 6 months.
!!! CYDY 2.5 BILLION REVENUE THIS YEAR !!!
You've stated numerous times Leronlimab is snake oil. So now are you saying you'll be bullish on snake oil??
There's a new chart out for CYDY, shows a soaring eagle formation July 15 2020. Gaps up to $8 and climbs to $20 over the next 3 days.
This is not a very good comparison at all. Not only is Leronlimab doing good in the lab it is doing extremely well on patients. And has multiple indications, not only working extremely well on cancer patients but also on HIV and Covid19.
WOW!! Nader personally saves the life of his neighbor!!!
The market responded showing CYDY price is holding strong. Over 20 tickers on my CV watchlist every one except two were red today with an average of -5%. And they all dropped first thing this morning. CYDY is moving with CV stocks only difference is Cytodyn's pipeline goes much deeper than CV, that keeps the value strong.
!NEWS OF MAJOR ACCOMPLISHMENTS OUT TODAY!
!!NEWS TOMORROW CYDY GOING UP!!
Not only perturbed, he's gonna lose big, ATHX is going to dump with CYDY approval
I read an article written about value of uplist. The writer, can't remember the publication, couldn't find any stats on uplist so he did his own small study of a number of uplisted and came up with an average of 25% gain in PPS with uplist. And almost all, except a small few, steadily gained throughout the following year. Which would go in hand with their growth and value from the reason they were able to uplist.
I'm thinking a good chance at an update for BTD. And NP last week was going to request the FDA take an early look at the eIND I believe, could be they agreed and are looking at the data.
CYDY financials are in great shape to carry them into revenue which is only weeks away. And not only are they in good shape they have 7 million carry over from last quarter.
Oh I agree with you there, something is most definitely brewing.
Big news out Tuesday, approval for covid, uplist to NYSE,
Another option is with a covid approval in as soon as 3 weeks, who knows could be sooner. Cytodyn has 40,000 viles of Leronlimab ready to go. I don't know the value exactly but at a minimum it could be 5 to 10 million. And with an approval in hand there will be no problem starting manufacturing there's another one million viles in a couple of months. NP was able to secure financing just on data alone, with an approval he should be able to get any backing he needs.
Here are the facts, not only has Cytodyn raised millions in the last couple of months, they have 7 million carry over from last quarter. That combined with available secured financing they are in Great shape.
After CYDY filing quarterly financial statement Feb 2020 Cytodyn has raised millions.
CYDY has 15 million in secured financing available. The beautiful part is they don't even need it.
CYDY has plenty of cash on hand, a manufacturing deal is in place with Samsung Biologics. Revenue will come streaming in within a couple of months.
NP and Kelly's stock sales were brilliant, allowing Cytodyn to raise funds for the uplist to NYSE
"regulatory developments" uplist to NYSE
They don't need financing. There is a manufacturing deal in place now. Revenue from Leronlimab will come rolling in. Cytodyn will be financing other companies.
Cytodyn secures 15 million in financing on the strength of data from Leronlimab. This is without even having revenue yet. Cytodyn has zero problem with financials.
CYDY patent protected drug Leronlimab has huge catalyst in the next coming weeks. As soon as next week. FDA approval for covid19 and uplist to NYSE. Big opportunity here to load up.
Strong opinions and unfortunately a few dishonest ones. But on a good note this board full of highly knowledgeable people with a wealth of information.
Great post Jenny! Thank you!! Welcome to the board
PRO 140 patents and applications relate to HIV-1, GvHD, immunomodulation and cancer treatments.
https://www.sec.gov/Archives/edgar/data/1175680/000119312519221300/d40614d10k.htm
Here is the drug patent for Leronlimab
But also keep in mind most immune compromised people are very careful with their health doing a better job at not catching the virus. Along those same lines perhaps Leronlimab patients that did catch it don't even know they had it because the benefit of Leronlimab. Maybe they could do a study, blood test for the antibody to see if they've had it.
News tommorow on eIND Patients
I just checked every chart available, none of them show the end points for the covid trial. I looked on the charts for the BLA also couldn't find that either. The chart doesn't even show the results from the eIND Patients that are being released tomorrow or Friday. Can you post a link for the chart that shows all that info??
Not exactly, CYDY also popped on their covid news in the beginning. Usually the pop doesn't hold, the hype wears off and the price drops, srne is seeing that now